Loading...
Thumbnail Image

Theses

Browse

Search Results

Now showing 1 - 1 of 1
  • ThesisItemOpen Access
    CANINE PYODERMA : DIAGNOSIS AND THERAPEUTIC MANAGEMENT
    (College of Veterinary Science, Assam Agricultural University, Khanapara, Guwahati, 2019-07) MARAK, SABETINI S.; Changkija, Bendangla
    The present study entitled “Canine pyoderma: Diagnosis and therapeutic management” was undertaken w.e.f. 1st August 2018 to 31st May 2019 with the objective to study the prevalence, identification of causative organism, hemato-biochemical alteration and to assess therapeutic efficacy in canine pyoderma. The overall prevalence of pyoderma in dogs was 14.59% with higher occurrence in Labrador breed (40%) with males (63.75%) being predominantly affected and in age group below 1 year (33.75%). Clinical signs associated with canine pyoderma were pruritis, pustules, alopecia, papule, scale and crust, patches, erythema, moth eaten appearance, dry coat, epidermal collaret, hyperpigmentation, abscess, lichnefication, edema, erosion and fissure. The causative organisms isolated from canine pyoderma were Staphylococcus species (100%) of which highest was Staphylococcus intermedius (43.75%) followed by Staphylococcus aureus (13.75%), coagulase negative Staphylococcus species (12.5%), Staphylococcus intermedius and Staphylococcus aureus (5%), Staphylococcus intermedius with Pseudomonas species (6.25%) and Staphylococcus intermedius with Klebsiella species (11.25%), Staphylococcus aureus with Pseudomonas species (5%) and Coagulase negative Staphylococcus species and Pseudomonas species (2.5%). The antibiotic sensitivity test for Staphylococcus intermedius isolates revealed highest sensitivity to linezolid (100%); Staphylococcus aureus to cephalexin and linezolid (94.73%); Coagulase negative Staphylococcus species to cephalexin and linezolid (100%); however gram negative organisms like Pseudomonas species and Klebsiella species revealed highest sensitivity to enrofloxacin (100%) but complete resistant to cephalexin and linezolid. Hematobiochemistry revealed anaemia (Low Hb and TEC), leukocytosis, neutrophilia, reduction in serum albumin, A:G ratio and zinc when compared with apparently healthy dogs. Dogs treated with cefpodoxime, ceftriaxone and tazobactum and linezolide showed faster recovery in clinical symptoms weekly than that of cephalexin and enrofloxacin but complete remission of clinical signs in all the animals was observed only in cephalexin treated group.